These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
334 related items for PubMed ID: 23891516
41. The stability of insulin-loaded polybutylcyanoacrylate nanoparticles in an oily medium and the hypoglycemic effect in diabetic rats. Hou ZQ, Zhang ZX, Xu ZH, Zhang H, Tong ZF, Leng YS. Yao Xue Xue Bao; 2005 Jan; 40(1):57-64. PubMed ID: 15881329 [Abstract] [Full Text] [Related]
45. Sol-gel transition of nanoparticles/polymer mixtures for sustained delivery of exenatide to treat type 2 diabetes mellitus. Oh KS, Kim JY, Yoon BD, Lee M, Kim H, Kim M, Seo JH, Yuk SH. Eur J Pharm Biopharm; 2014 Nov 02; 88(3):664-9. PubMed ID: 25152212 [Abstract] [Full Text] [Related]
49. The glucose-lowering potential of exenatide delivered orally via goblet cell-targeting nanoparticles. Li X, Wang C, Liang R, Sun F, Shi Y, Wang A, Liu W, Sun K, Li Y. Pharm Res; 2015 Mar 02; 32(3):1017-27. PubMed ID: 25270570 [Abstract] [Full Text] [Related]
50. Effective insulin delivery using starch nanoparticles as a potential trans-nasal mucoadhesive carrier. Jain AK, Khar RK, Ahmed FJ, Diwan PV. Eur J Pharm Biopharm; 2008 Jun 02; 69(2):426-35. PubMed ID: 18295464 [Abstract] [Full Text] [Related]
51. Exendin-4 improves the oral glucose tolerance in diabetic rats: pancreas regeneration, better function of pancreatic islets, or impaired glucose uptake? Strauss A, Moskalenko V, Chodnevskaja I, Timm S, Thiede A, Otto C, Ulrichs K. Transplant Proc; 2008 Mar 02; 40(2):533-5. PubMed ID: 18374122 [Abstract] [Full Text] [Related]
52. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery. Liu M, Zhang J, Zhu X, Shan W, Li L, Zhong J, Zhang Z, Huang Y. J Control Release; 2016 Jan 28; 222():67-77. PubMed ID: 26686663 [Abstract] [Full Text] [Related]
53. [Study on preparation and oral efficacy of insulin-loaded poly(lactic-co-glycolic acid) nanoparticles]. Pan Y, Xu H, Zhao HY, Wei G, Zheng JM. Yao Xue Xue Bao; 2002 May 28; 37(5):374-7. PubMed ID: 12579845 [Abstract] [Full Text] [Related]
54. [D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, augments the effects of orally delivered exenatide and pramlintide acetate on energy balance and glycemic control in insulin-resistant male C57BLK/6-m db/db mice. Leinung MC, Grasso P. Regul Pept; 2012 Nov 10; 179(1-3):33-8. PubMed ID: 22960403 [Abstract] [Full Text] [Related]
55. Overcoming Multiple Absorption Barrier for Insulin Oral Delivery Using Multifunctional Nanoparticles Based on Chitosan Derivatives and Hyaluronic Acid. Chen Z, Han S, Yang X, Xu L, Qi H, Hao G, Cao J, Liang Y, Ma Q, Zhang G, Sun Y. Int J Nanomedicine; 2020 Nov 10; 15():4877-4898. PubMed ID: 32753869 [Abstract] [Full Text] [Related]
56. [Poly(arginine)8 enhanced intestinal absorption of insulin-loaded nanoparticles]. Liu XL, Zhang WJ, Wei G, Lu WY. Yao Xue Xue Bao; 2012 Apr 10; 47(4):512-6. PubMed ID: 22799036 [Abstract] [Full Text] [Related]
57. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport. Jin Y, Song Y, Zhu X, Zhou D, Chen C, Zhang Z, Huang Y. Biomaterials; 2012 Feb 10; 33(5):1573-82. PubMed ID: 22093292 [Abstract] [Full Text] [Related]